Larimar Therapeutics, Inc. Ratios

Ratios Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019
Profitability
EBT Margin 14,317.53%4,180.92%9,203.60%10,937.62%31,616.97%3,220.81%2,572.54%
EBIT Margin 14,217.53%4,084.14%9,157.94%11,006.62%32,120.61%3,220.34%2,585.16%
EBITDA Margin 14,309.28%4,196.90%9,237.97%10,917.01%31,518.79%3,231.98%2,567.27%
Operating Margin 14,217.53%4,084.14%9,157.94%11,006.62%32,120.61%3,220.34%2,585.16%
Net Margin 14,378.35%4,203.45%9,216.63%10,941.02%7,930.30%767.65%2,572.54%
FCF Margin 14,011.34%3,252.76%7,462.66%9,949.91%26,569.09%2,718.39%1,290.03%
Efficiency
Assets Average 77.83M153.31M160.36M118.57M113.64M63.48M
Equity Average -61.65M17.93M136.78M145.42M99.97M85.74M46.29M
Invested Capital -54.73M-68.57M104.44M169.11M121.73M78.22M93.27M-0.69M
Asset Utilization Ratio -0.01-0.010.000.00-0.02-0.03
Leverage & Solvency
Interest Coverage Ratio -142.18-40.84-91.58-110.07-321.21-32.20-25.85
Debt to Equity 0.060.020.260.16-12.20
Debt Ratio 0.050.020.190.121.63
Equity Ratio -1.800.890.890.920.740.77-0.13
Times Interest Earned -142.18-40.84-91.58-110.07-321.21-32.20-25.85
Valuation
Enterprise Value -9.94M-35.52M584.83M-13.77M-42.28M24.95M64.44M-2.57M
Market Capitalization 700.30M171.31M86.92M127.00M182.51M41.49M
Return Ratios
Return on Sales 143.18%41.81%92.04%109.38%316.17%32.21%25.73%
Return on Capital Employed -0.50%-0.54%-0.39%-0.48%-0.61%-0.79%
Return on Assets -0.47%-0.48%-0.36%-0.44%-0.54%-0.72%
Return on Equity 0.22%-2.03%-0.54%-0.40%-0.52%-0.71%-0.98%